Davey, Robert A.

Network medicine framework for identifying drug-repurposing opportunities for COVID-19

Morselli Gysi, D., do Valle, Í., Zitnik, M., Ameli, A., Gan, X., Varol, O., Ghiassian, S. D., Patten, J. J., Davey, R. A., Loscalzo, J., et al. (2021) · Proceedings of the National Academy of Sciences

Computational Drug Discovery MethodsSARS-CoV-2 and COVID-19 Research

Cited by 107

The natural product eugenol is an inhibitor of the ebola virus in vitro

Lane, T., Anantpadma, M., Freundlich, J. S., Davey, R. A., Madrid, P. B., & Ekins, S. (2019) · Pharmaceutical Research

Viral Infections and Outbreaks ResearchMedicinal Plant Research

Cited by 88

Machine learning models identify molecules active against the Ebola virus in vitro

Ekins, S., Freundlich, J. S., Clark, A. M., Anantpadma, M., Davey, R. A., & Madrid, P. (2015) · F1000Research

Computational Drug Discovery MethodsViral Infections and Outbreaks Research

Cited by 84

Ebola Virus Bayesian Machine Learning Models Enable New in Vitro Leads

Anantpadma, M., Lane, T., Zorn, K. M., Lingerfelt, M. A., Clark, A. M., Freundlich, J. S., Davey, R. A., Madrid, P. B., & Ekins, S. (2019) · ACS Omega

Computational Drug Discovery MethodsViral Infections and Outbreaks Research

Cited by 54

A stapled lipopeptide platform for preventing and treating highly pathogenic viruses of pandemic potential

Bird, G. H., Patten, J. J., Zavadoski, W., Barucci, N., Godes, M., Moyer, B. M., Owen, C. D., DaSilva-Jardine, P., Neuberg, D. S., Bowen, R. A., et al. (2024) · Nature Communications

SARS-CoV-2 and COVID-19 ResearchChemical Synthesis and Analysis

Cited by 22